Ann Coloproctol 2015;31(5):172-173 http://dx.doi.org/10. 3393/ac.2015.31.5.172 Colorectal patients who undergo radical surgery are vulnerable to the development of a venous thromboembolism (VTE). A VTE and a pulmonary embolism (PE) can result in chronic leg swelling, ulceration, and discomfort (postthrombotic syndrome), or even death [1] . A number of factors that increase the risk of a postoperative VTE have been identified. In addition to the surgical procedure itself, these include a history of previous VTE, cancer, inflammatory bowel disease, thrombophilia, old age, obesity, smoking, acute illness, wound infection, and prolonged immobilization [2] [3] [4] . Therefore, interest exists in better characterizing the specific risk factors for a VET, especially a PE, in patients undergoing colorectal surgery. This could help determine strategies for preventing a VTE, as well as PE, in this complex patient population. Furthermore, questions remain regarding the optimal duration of prophylaxis, patient selection, and the real effect of VTE prophylaxis.
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Although multiple trials have demonstrated the efficacy of VTE prophylaxis, a number of reports have also suggested that perioperative VTE prophylaxis is underutilized in clinical practice. The prospective United States VTE Free Study reported that less than one half of the 1,375 patients who had undergone nonorthopedic surgeries and had developed an ultrasound-confirmed VTE had received VTE prophylaxis [5] . In addition, the American College of Chest Physicians Consensus Conference on Antithrombotic Therapy found a VTE prophylaxis compliance of only 13% [6] . Extended VTE prophylaxis has the potential to negatively influence patient outcomes and may actually lead to bleeding complications in the immediate postoperative period. Surgeons may also be more reluctant to perform imaging procedures when the patient's condition is questionable.
Recent prospective data showed the lack of any benefit from an aggressive VTE prevention strategy; among 16,120 patients undergoing colorectal surgery, the use of perioperative and in-hospital VTE prophylaxis increased significantly from 32% to 86% and from 60% to 91%, respectively, between 2006 and 2011 [7] . Despite this increase, no change in the VTE rates was observed over time. The overall incidence of a VTE remained low, at 2.2%. Another recent study from 2,838 hospitals in the United States indicated that hospitals with characteristics suggestive of higher quality (e.g., more accreditations) had higher VTE chemoprophylaxis rates, but paradoxically had worse risk-adjusted VTE rates [8] . Therefore, VTE rates seem to be influenced more by the utilization rates for hospital VTE imaging than by adherence to VTE prevention strategies.
Based on emerging evidence, further investigations of VTE chemoprophylaxis in patients undergoing colorectal surgery, by using a nation-wide study in Korea, may be necessary. These results may influence future studies looking specifically at prophylaxis guidelines.
